Two BioDiscovery Applications Achieve GeneChip-compatible™ Status with the Affymetrix GeneChip® Microarray Platform
BioDiscovery, Inc. today announced that two of its products have achieved GeneChip-compatible™ status with the Affymetrix Inc. GeneChip microarray platform and that it has joined Affymetrix GeneChip-compatible™ Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development. As a GeneChip-compatible software provider, BioDiscovery, Inc. is committed to seamlessly integrating its GeneDirector® and GeneSight® products with Affymetrix technology.
GeneDirector® is a comprehensive data management solution for information generated throughout the entire array experiment workflow, including sample preparation, protocols, hybridization, image and data analysis. GeneDirector features integrated tools and functionality which include full GCOS integration supporting the Affymetrix platform. It is designed to be both flexible and customizable to meet any laboratory requirements. The centralized data management functionality allows immediate data access, impenetrable security, and cross experiment analysis.
GeneSight® combines advanced normalization, visualization, and statistical decision support tools into a single powerful package. The unique Confidence Analyzer tool can use replicated gene expression data for identifying genes having true differential expression. The Significance Analyzer tool can determine genes with statistically significant expression patterns and differentiate between classes of experimental conditions, such as disease states. The Integrated Annotation Complier supports Affymetrix annotation files and annotations from other public databases.
“BioDiscovery is delighted that two of its products have achieved GeneChip-compatible status with Affymetrix,” said Dr. Soheil Shams, President of BioDiscovery, “Our mission is to provide solutions and services to enable our customers to revolutionize drug discovery and diagnostics. We see this integration between GeneDirector, GeneSight, and the Affymetrix GeneChip® microarray platform as another vital component of our mission.”
“Data management and data analysis technologies are key components for any successful high volume GeneChip laboratory” said Steve Lincoln, vice president of Informatics at Affymetrix. “We look forward to continuing our longstanding interaction with BioDiscovery to establish key standards in the marketplace and maintain compatibility as our GeneChip technology continues to evolve.”
About the Affymetrix Developers Network (ADN)
Through one of the largest third-party software developer communities within the life science industry, Affymetrix works with its partners to provide a broad spectrum of solutions for leveraging gene expression and genetic variation analysis in both biomedical research and development. Membership in ADN is free of charge for both commercial and academic software developers. For more information please visit www.affymetrix.com/genechip/developer . Visit the GeneChip-compatible Software Solutions Catalog at www.affymetrix.com/genechip/compatible .
About Affymetrix:
Affymetrix scientists invented the world’s first microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip® technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world’s top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,200 systems have been shipped around the world and more than 3,000 peer-reviewed papers have been published using the technology. Affymetrix’ patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyze the relationship between genetics and health. Headquartered in Santa Clara, Calif., Affymetrix has subsidiaries in Europe and Asia in addition to manufacturing facilities in Sacramento, Calif. and Bedford, Mass. The company has about 900 employees worldwide. For more information about Affymetrix, please visit the company’s website at www.Affymetrix.com
About BioDiscovery, Inc.:
Founded in 1997 in Los Angeles, BioDiscovery is a leader in the development of microarray bioinformatics software and services. BioDiscovery develops and sells advanced software solutions and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. BioDiscovery provides a full line of modular software packages spanning the entire microarray process, including enterprise data management, image processing, data mining, statistical analysis, and collaborative knowledge management. For more information about BioDiscovery, please visit the company’s website at www.biodiscovery.com .
